Differential expression of p16(INK4a) and p16β transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations

Helen Rizos*, Therese M. Becker, Elizabeth A. Holland, Richard F. Kefford, Graham J. Mann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Mutations in the CDKN2A (p16(INK4a)) tumour suppressor gene on chromosome 9p21 are associated with inherited predisposition to melanoma, yet some 9p-linking hereditary melanoma families show no mutations in this gene. Splicing of CDKN2A exons 2 and 3 to an alternative first exon produces a transcript (p16β) encoding a protein with cell cycle regulatory properties. We have analysed allele-specific expression levels of both the p16(INK4a) and p16β transcripts in B-lymphoblastoid cells from 18 members of hereditary melanoma kindreds including four unrelated control individuals. In 15 of the 18 individuals examined, steady-state levels of each transcript either originated equally from each parental chromosome, or one parental chromosome was dominant for both transcripts. However, in three affected members of two 9p-linking hereditary melanoma kindreds, without exonic CDKN2A mutations, this pattern of coordinate expression was disrupted. In these individuals there was underexpression of the p16β transcript, relative to the p16(INK4a) transcript, from the chromosome segregating with disease susceptibility. Loss of coordinate expression of the p16(INK4a) and p16β transcripts may be an alternative genetic basis for melanoma susceptibility in certain 9p-linking kindreds.

Original languageEnglish
Pages (from-to)515-523
Number of pages9
JournalOncogene
Volume15
Issue number5
Publication statusPublished - 1997
Externally publishedYes

Keywords

  • Hereditary melanoma
  • p16β
  • p16(INK4a)

Fingerprint

Dive into the research topics of 'Differential expression of p16(INK4a) and p16β transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations'. Together they form a unique fingerprint.

Cite this